Heartburn meds tapped in coronavirus treatment
New York hospitals testing heartburn drug Pepcid as potential coronavirus treatment
Johns Hopkins School of Public Health Professor Dr. Marty Makary provides insight into Pepcid as a possible coronavirus treatment, antibody testing and which businesses can best function safely during a pandemic.
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
Continue Reading Below
Researchers at a New York hospital system are looking into a common heartburn drug as a possible coronavirus treatment in combination with hydroxychloroquine.
Americans have been taking famotidine, also known by the brand name Pepcid, for years. The famotidine/hydroxychloroquine trial is one of six being run by the Feinstein Institutes for Medical Research, the science wing of Northwell Health.
CORONAVIRUS PATIENT STUDY RAISES QUESTIONS ABOUT WHETHER TEMPERATURE CHECKS WORK
The trial started in mid-March and includes 150 people. Patients receive the treatment intravenously three times a week.